ET-24 A NOVEL TROJAN HORSE FOR IN-VIVO SENSITIVITY TESTING OF MEDULLOBLASTOMA THERAPIES

Por Jonas, Oliver, Sengupta, Soma, Calligaris, David, Poe, Michael, Methuku, Kashi, Francois, Jessica Pierre, Cook, James, Agar, Nathalie, Pomeroy, Scott, Langer, Robert
Publicado em 2014

First in vivo testing of compounds targeting Group 3 medulloblastomas using an implantable microdevice as a new paradigm for drug development

Por Jonas, Oliver, Calligaris, David, Methuku, Kashi Reddy, Poe, Michael M., Francois, Jessica Pierre, Tranghese, Frank, Changelian, Armen, Sieghart, Werner, Ernst, Margot, Pomeranz Krummel, Daniel A., Cook, James M., Pomeroy, Scott L., Cima, Michael, Agar, Nathalie YR, Langer, Robert, Sengupta, Soma
Publicado no J Biomed Nanotechnol (2016)

MEDULLOBLASTOMA EXOME SEQUENCING UNCOVERS SUBTYPE-SPECIFIC SOMATIC MUTATIONS

Por Pugh, Trevor J., Weeraratne, Shyamal Dilhan, Archer, Tenley C., Pomeranz Krummel, Daniel A., Auclair, Daniel, Bochicchio, James, Carneiro, Mauricio O., Carter, Scott L., Cibulskis, Kristian, Erlich, Rachel L., Greulich, Heidi, Lawrence, Michael S., Lennon, Niall J., McKenna, Aaron, Meldrim, James, Ramos, Alex H., Ross, Michael G., Russ, Carsten, Shefler, Erica, Sivachenko, Andrey, Sogoloff, Brian, Stojanov, Petar, Tamayo, Pablo, Mesirov, Jill P., Amani, Vladimir, Teider, Natalia, Sengupta, Soma, Francois, Jessica Pierre, Northcott, Paul A., Taylor, Michael D., Yu, Furong, Crabtree, Gerald R., Kautzman, Amanda G., Gabriel, Stacey B., Getz, Gad, Jäger, Natalie, Jones, David T. W., Lichter, Peter, Pfister, Stefan M., Roberts, Thomas M., Meyerson, Matthew, Pomeroy, Scott L., Cho, Yoon-Jae
Publicado em 2012